Company profile for Livzon Pharmaceutical Group

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Livzon Pharmaceutical Group Inc., established in January 1985 with registered capital of 935 million yuan, is a comprehensive pharmaceutical group company integrating pharmaceutical R&D, production, and sales with more than 8,000 employees and is one of the few listed pharmaceutical companies with A+H shares in the capital market. Livzon continues to make breakthroughs in areas of APIs, chemical drugs, traditional Chinese medi...
Livzon Pharmaceutical Group Inc., established in January 1985 with registered capital of 935 million yuan, is a comprehensive pharmaceutical group company integrating pharmaceutical R&D, production, and sales with more than 8,000 employees and is one of the few listed pharmaceutical companies with A+H shares in the capital market. Livzon continues to make breakthroughs in areas of APIs, chemical drugs, traditional Chinese medicine, biological drugs and in vitro diagnostics, etc. Involving digestive,cardio-cerebrovascular, reproductive endocrinology, psychotropic/neurological, and other fields.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R
Telephone
Telephone
+ 86 756-8135888
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.reuters.com/business/healthcare-pharmaceuticals/second-chinese-drugmaker-seeks-approval-ozempic-generic-2024-06-14/

Andrew Silver REUTERS
13 Jun 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/livzon-pharmas-covid-19-vaccine-gets-emergency-use-approval-china-2022-09-02/

REUTERS
03 Sep 2022

https://en.livzon.com.cn/news/277.html

PRESS RELEASE
20 Apr 2022

https://en.livzon.com.cn/news/278.html

PRESS RELEASE
20 Apr 2022

https://en.livzon.com.cn/news/276.html

PRESS RELEASE
20 Apr 2022

https://en.livzon.com.cn/news/275.html

PRESS RELEASE
20 Apr 2022

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Livzon Pharmaceutical Group and get a quotation

Livzon Pharmaceutical Group is a supplier offers 4 products (APIs, Excipients or Intermediates).

Find a price of Daptomycin bulk with JDMF offered by Livzon Pharmaceutical Group

Find a price of Human Chorionic Gonadotropin bulk with DMF offered by Livzon Pharmaceutical Group

Find a price of Lincomycin Hydrochloride bulk offered by Livzon Pharmaceutical Group

Find a price of Mycophenolic Acid bulk with DMF offered by Livzon Pharmaceutical Group

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty